Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $96.0 million.

  • Veracyte's Net Cash Flow rose 15255.72% to $96.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.7 million, marking a year-over-year decrease of 4165.78%. This contributed to the annual value of $23.7 million for FY2024, which is 6183.91% down from last year.
  • Per Veracyte's latest filing, its Net Cash Flow stood at $96.0 million for Q3 2025, which was up 15255.72% from $32.8 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Net Cash Flow ranged from a high of $96.0 million in Q3 2025 and a low of -$163.6 million during Q3 2021
  • Its 5-year average for Net Cash Flow is -$1.6 million, with a median of $9.0 million in 2021.
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 35273.7% in 2023, then tumbled by 66150.75% in 2025.
  • Over the past 5 years, Veracyte's Net Cash Flow (Quarter) stood at $9.0 million in 2021, then crashed by 284.33% to -$16.6 million in 2022, then surged by 182.55% to $13.7 million in 2023, then tumbled by 349.1% to -$34.1 million in 2024, then soared by 381.29% to $96.0 million in 2025.
  • Its Net Cash Flow stands at $96.0 million for Q3 2025, versus $32.8 million for Q2 2025 and -$52.9 million for Q1 2025.